Searchable abstracts of presentations at key conferences in endocrinology

ea0026p724 | Diabetes (epidemiology, pathophysiology) | ECE2011

TCF7L2 gene variants and plasma C-peptide concentrations in diabetes type 2

Ferreira M C , Marques M C A , Fukui R T , Correia M R , Silva M E R , Rocha D M , Santos R F

Aims/hypothesis: Several data have shown the association between diabetes type 2 (DM2) and transcription factor 7-like 2 (TCF7L2) gene polymorphisms, in several and different ethnical populations. Although the pathophysiology is not completely clear, it seems that beta and alpha cell functions are abnormal. Up to these days there is no clinical data showing association between TCF7L2 gene polymorphism allele rs7903146 T and beta cell insulin and C-peptide contents in DM2 patie...

ea0026s16.3 | TSH Receptor and thyroid disorders | ECE2011

Small molecule TSH receptor agonists and antagonists

Neumann S , Gershengorn M C

TSH activates the TSH receptor (TSHR) thereby stimulating the function of thyroid follicular cells (thyrocytes) leading to biosynthesis and secretion of thyroid hormones. Because TSHR is involved in several thyroid pathologies there is a strong rationale for the design of small molecule ‘drug-like’ ligands (SMLs).rhTSH (ThyrogenR) has been used in the follow-up of patients with thyroid cancer to increase the sensitivity for detection...

ea0026p676 | Diabetes therapy | ECE2011

Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control

Hsieh Y T , Hsieh M C , Tu S T

Background: Asian has higher prevalence of diabetic nephropathy and end-stage renal disease as compared to Caucasian. No study to date has evaluated whether multifactorial intervention was associated with remission of microalbuminuria in type 2 diabetic Asian population. We evaluated the effect of tightly controlling multiple factors on the remission of diabetic nephropathy in type 2 diabetic Chinese with microalbuminuria.Materials and methods: A total o...

ea0004oc14 | Endocrine tumours and neoplasia | SFE2002

ANGIOTENSIN II INDUCES C-FOS EXPRESSION THROUGH PKC-zeta IN MCF-7 BREAST CANCER CELL LINE

Muscella A , Greco S , Elia M , Storelli C , Marsigliante S

It has been reported that Ang II induces the growth of MCF-7 breast cancer cells (Muscella et al., J Endocrinol 173, 315-323, 2002). Here we have examined the signalling pathways evoked by Ang II in MCF-7. Ang II did not change the concentration of intracellular calcium but induced the cytosol-to-membrane translocation of atypical protein kinase C zeta (PKC-zeta). Ang II dose-dependently induced c-fos (mRNA and protein) and enhanced the phosphorylation state of extracellular s...

ea0026p486 | Thyroid cancer | ECE2011

mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures

Filieri C , Zatelli M C , Minoia M , Tagliati F , Buratto M , Ambrosio M R , Pelizzo M , degli Uberti E C

It has been demonstrated that everolimus, an mTOR inhibitor, has potent anti-proliferative effect in a human Medullary Thyroid Carcinoma (MTC) cell line, TT, and in two human MTC primary cultures. We aimed at evaluating the possible antiproliferative effects of everolimus in a group of 20 human MTC in primary culture. To this purpose, 20 MTCs were dispersed in primary cultures, treated without or with 1 nM – 1 μM everolimus, 10 nM SOM230, and/or 50 nM IGF1. Cell viab...

ea0026p180 | Neuroendocrinology | ECE2011

Targeting PKC in human pancreatic neuroendocrine tumor cells

Mole D , Gagliano T , Gentilin E , Bondanelli M , Tagliati F , degli Uberti E , Zatelli M C

The currently curative therapy for pancreatic endocrine tumours (PET), accounting for <3% of pancreatic tumors, is complete surgical resection, which is achieved in the minority of cases. Most tumors are diagnosed in a late stage, especially in endocrine-inactive forms, indicating the need for further medical therapy. The serine–threonine protein kinase C (PKC) family plays central regulatory roles in several cellular processes, including cell proliferation. PKC signa...

ea0026p80 | Endocrine tumours and neoplasia | ECE2011

Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line

Gagliano T , Robustelli A R , Mole D , degli Uberti E , Zatelli M C

Adrenocortical carcinoma (ACC), a rare tumor, with incidence of 1–2 per million population annually, has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30–40 years old. ACC has a dismal prognosis. The only curative treatment is complete surgical excision of the tumor, but late diagnosis prevents surgical cure, since ACC frequently recurs and metastasize. Chemotherapy is frequently ineffective, due to the overexpression of the ...

ea0011p782 | Thyroid | ECE2006

Correlation between endogenous thyroxin and A, G, and M immunoglobulins in dysthyreosis

Laszlo A , Pascanu I , Gliga C , Schiopu A , Laszlo M

Introduction: The thyroid is a multifunctional endocrine gland which, by its hormones, affects all the organs, metabolisms and nonspecific defence of the body. The aim of this study is to establish if endogenous thyroxin (FT4) is involved in the nonspecific defence of the organism.Material and methods: 94 patients were included in the study, 47 with hyperthyroidism and 47 with hypothyroidism, 81 women, 13 men aged 7–78. FT4 was...

ea0026p270 | Pituitary | ECE2011

Primary empty sella is associated with increased cardiovascular risk, regardless the occurrence of pituitary dysfunction

Torre M L , Cotta O R , Ferrau F , Di Mauro E , Albani A , Boschetti M , Teti C , Savanelli M C , Di Somma C , Alibrandi A , Ferone D , Cannavo S , Colao A

Introduction: Primary empty sella (PES) is a frequent ‘incidental’ finding reported in 5–25% of general population and is associated with endocrine abnormalities in 8–60% of cases. In this collaborative multicentric study we evaluated cardiovascular risk by assessing clinical characteristics, glucidic profile and lipid parameters.Design: A total of 94 PES patients (39M-55F; mean age 50.3±0.9 years; mean BMI 28.9±0.5 kg/m<sup...

ea0003p211 | Reproduction | BES2002

Parathyroid polyhormone action on motility of pregnant mouse uterus in vitro: Role of nitric oxide

Francis M , Precious S , Brown J , Dacke C

The effects of N-terminal parathyroid hormone (PTH) and parathyroid hormone related peptides (PTHrP) on the spontaneous contractility of 4 days pregnant mouse uterus in vitro were investigated. The myometrial tissue contracted vigorously for several hours, when incubated in organ baths in De Jalon's solution. PTH(1-34) and PTHrP(1-40) caused similar dose related inhibitions of contractions over a dose range of 10-9 to 10-7 M. C terminal PTHrP(107-139) was devoid of this...